Clinical Writing for Interventional Cardiologists
description
Transcript of Clinical Writing for Interventional Cardiologists
Clinical Writing for Interventional Cardiologists
What you will learn - hopefully!• Introduction• General principles for clinical writing• Specific techniques• Practical session: critical review of a published article• Writing the Title and the Abstract• Bibliographic search and writing the Introduction• Principles of statistics and writing the Methods• Practical session: writing the Abstract• Writing the Results• Writing the Discussion• Writing Tables and preparing Figures• Principles of peer-review• Principles of grant writing/regulatory submission• Clinical writing at a glance• Conclusions and take home messages
What you will learn• Bibliographic search and writing the Introduction
– methods of bibliographic search– most popular databases, including Google Scholar,
PubMed, Web of Science– goals of Introduction– effective tips for Introduction
What you will learn• Bibliographic search and writing the Introduction
– methods of bibliographic search– most popular databases, including Google Scholar,
PubMed, Web of Science– goals of Introduction– effective tips for Introduction
What to choose for a bibliographic search?
Simple and easy-going
or …
fast but tough?
Seniors, juniors, and colleagues
Textbooks
Medical journals
World wide web
1st step: framing the question
• Population: who are the relevant patients?
• Intervention or exposure: what are the management
strategies we want to appraise or the relevant harmful exposure
we want to study?
• Outcome: what are the patient-relevant consequences of
the exposure in which we are interested?
1st step: framing the question
2nd step: determining question type
• Therapy: determining the effect of different treatments on improving
patient function and avoiding adverse events
• Harm: ascertaining the effects of potentially harmful agents on patient
function, morbidity, and mortality
• Diagnosis: establishing the power of an intervention to differentiate
between those with and those without a target condition or disease
• Prognosis: estimating the future course of a patient’s disease
2nd step: determining question type
1st step: example
• All-purpose question: are 1st generation DES safe?
• Improved (searchable) question:
Population: patients with acute or chronic coronary disease
undergoing PCI
Intervention/Comparison: implantation of 1st generation DES
(Intervention) vs BMS (Comparison) – randomized allocation
Outcome(s): death, myocardial infarction, stroke, repeat
revascularization, stent thrombosis, rehospitalizations, costs
2nd step: example
• Therapy: which embolic protection device is more effective
and safe?
• Harm: what is the risk of stent fracture with DES?
• Diagnosis: can I recognize which angiographically-
intermediate coronary lesions are functionally significant?
• Prognosis: can I predict which patients are more likely to
develop stent thrombosis if treated with DES?
What you will learn• Bibliographic search and writing the Introduction
– methods of bibliographic search– most popular databases, including Google Scholar,
PubMed, Web of Science– goals of Introduction– effective tips for Introduction
WWW resources• BioMedCentral: www.biomedcentral.com
• Clinical Trial Results: www.clinicaltrialresults.org/
• Clinicaltrials.gov: www.clinicaltrials.gov
• DARE: www.york.ac.uk/inst/crd/crddatabases.htm
• EMBASE: www.embase.com
• Google Scholar: scholar.google.com
• Medscape: www.medscape.com
• meta Register of Controlled Trials (mRCT): www.controlled-trials.com/mrct/
• PubMed: www.pubmed.gov
• The Cochrane Library: www.cochrane.org
• UpToDate: www.uptodate.com
• WebMD: www.webmed.com
• Web of Science: isiknowledge.com
WWW resources• BioMedCentral: www.biomedcentral.com
• Clinical Trial Results: www.clinicaltrialresults.org/
• Clinicaltrials.gov: www.clinicaltrials.gov
• DARE: www.york.ac.uk/inst/crd/crddatabases.htm
• EMBASE: www.embase.com
• Google Scholar: scholar.google.com
• Medscape: www.medscape.com
• meta Register of Controlled Trials (mRCT): www.controlled-trials.com/mrct/
• PubMed: www.pubmed.gov
• The Cochrane Library: www.cochrane.org
• UpToDate: www.uptodate.com
• WebMD: www.webmed.com
• Web of Science: isiknowledge.com
BioMedCentral
• BioMedCentral is provided by a private UK
company (the same that provides mRCT)
• It mostly contains open access journals or
conference proceedings
• It may be a useful and cheap (it’s free!) starting
point, but to date its content is limited
• In the future however it should vastly expand
BioMedCentral
Clinical Trial Results
• CTR is provided for free by C.M. Gibson
(the author of the TIMI frame count
and TIMI myocardial perfusion grade)
• It contains pre-publication data from recent
clinical trials
• However, it is not comprehensive and its scope
largely reflects the interests of its developer (ie
coronary disease)
Clinical Trial Results
clinicaltrials.gov
• clinicaltrials.gov is the FDA-supported and
recommended registry of prospective studies
• It contains protocols of ongoing or recently
completed trials
• Registration in clinicaltrials.gov or similar
registries is now mandatory to be eligible for
publication of prospective studies in major
journals
clinicaltrials.gov
DARE
• The Database of Abstracts of Reviews of
Effectiveness is provided for free by the University
of York
• It contains titles and abstracts of systematic reviews
of effectiveness
• Each item contained (ie systematic reviews) is a
very good starting point to get info on a topic
• However, some hits are obsolete and no papers on
prognosis, diagnosis, or pathophysiology are
included to date
DARE
EMBASE
• EMBASE is a comprehensive archiving site,
provided for a fee by Elsevier
• Its scope is similar but greater and largely non-
overlapping with MEDLINE/PubMed
• It may be useful for sophisticated researchers and
systematic reviewers
• However, it’s expensive and rarely needed, as most
important papers will be already in MEDLINE/
PubMed
EMBASE
Google Scholar
Google Scholar • Scholar Google is provided for free by Google
• It contains citations and direct links to abstracts or full text
articles
• In addition, it enables citation analysis, thus forward and
backward snowballing
• It’s not yet very structered, and highly relevant citations
might not be included or missed because buried among
thousands of non-relevant ones
MEDSCAPE
• A freely surfable website providing disparate
content, now owned by the WebMD company
• The Cardiology section is often updated and may
provide recent data on trials or other news
• It is not developed or maintained systematically,
and thus lacks comprehensiveness
MEDSCAPE
mRCT
• The meta Register of Controlled Trials is a freely
searchable website containing data on registered
trials
• It is provided by the owner of BioMedCentral
• It’s a good source on recent or ongoing (thus
unpublished) trials
• While interesting for the clinical researcher or
meta-analyst, it’s scope is limited to RCT
mRCT
PubMed
• PubMed is the web (and free) version of MEDLINE
(provided by the US National Library of Medicine)
• It contains data on articles printed every day in several
thousands medical journals around the world, even if there
is some bias toward US and English-language publications
• It is reasonably comprehensive and sophisticated,
especially for the expert user
• Nonetheless, many papers can still be missed by the
MEDLINE indexers, and using PubMed requires some
expertise
PubMed
PubMed: tips and tricksThere are 4 basic ways to search PubMed:
• Free text searches• Searches with descriptors (Medical Subject Headings,
MeSH) • Clinical queries (specific filters for studies or topics)• Limits (enable the searcher to select several
characteristics, such as language, article type, study type, and so forth)
• History
The ideal search combines one or more of such instruments to obtain precise and concise answers to the clinical question
Free text searches
MeSH
Limits
Clinical queries
History
Where to learn how to use PubMed?
The Cochrane Collaboration
• The Cochrane Collaboration provides abstracts of
systematic reviews for free and full texts and additional
services for a fee
• It contains the most rigorous systematic reviews available
to date on treatment
• No comprehensive systematic reviews are yet available for
other topics
• Many reviews, while highly valid and pertinent, might be
outdated because of infrequent updates
The Cochrane Collaboration
UpToDate
• UpToDate is provided for a fee by an American company
• It provides qualitative reviews of most topics, with the
specific features that reviews are updated very frequently
• No strict methodology for review production or update is
enforced
• In addition, it might seem superficial and not detailed
enough for experts of a topic
UpToDate
WebMD
• WebMD is a comprehensive website for healthcare
professional, that can be accessed upon fee
subscription
• It is relatively comprehensive but unstructured
• Resembles (albeit with less cardiovascular focus)
www.crtonline.org, www.medscape.com,
www.theheart.org, and www.tctmd.com
WebMD
Web of Science
• Provided for an expensive fee by Thompson-Institute for
Scientific Indexing, is the basis for the computation of
impact factors and citation indexes
• Contains titles and abstracts from several thousands
journals
• In addition, it enables forward and backward snowballing
• However, it lacks the comprehensiveness of EMBASE or
PubMed
Web of Science
Questions?
Take home messages
The most important tips to remember
when looking for scientific literature are:
Take home messages
The most important tips to remember
when looking for scientific literature are:
1 – begin with a broad search: it you find too much,
you can always refine the search later on
Take home messages
The most important tips to remember
when looking for scientific literature are:
1 – begin with a broad search: it you find too much,
you can always refine the search later on
2 – use as starting points authoritative investigators,
seminal papers and/or clear-cut key-words
Take home messages
What you will learn• Bibliographic search and writing the Introduction
– methods of bibliographic search– most popular databases, including Google Scholar,
PubMed, Web of Science– goals of Introduction– effective tips for Introduction
Introduction
What question (problem) was studied and
what is your underlying hypothesis?
Introduction
What question (problem) was studied and
what is your underlying hypothesis?
The answer is in the Introduction.
Introduction
• Catches and keeps the reader’s interest
• Uses a “funnel” type of organization
• Includes KUQE, ie Known, Unknown, the
Question, and then introduces the
Experimental approach:
– The nature and scope of the problem
– The gap or general problem
– Previous findings & pertinent literature
– The method of investigation
– The hypothesis/research question
Introduction
Expanded IMRAD algorithm
Introduction BackgroundLimitations of current evidenceStudy hypothesis
Methods DesignPatientsProceduresFollow-upEnd-pointsAdditional analysesStatistical analysis
Results Baseline and procedural dataEarly outcomesMid-to-long term outcomesAdditional analyses
Discussion Summary of study findingsCurrent research contextImplications of the present studyAvenues for further researchLimitations of the present studyConclusions
What you will learn• Bibliographic search and writing the Introduction
– methods of bibliographic search– most popular databases, including Google Scholar,
PubMed, Web of Science– goals of Introduction– effective tips for Introduction
• Pose the problem in few sentences
• Review the current literature briefly and in a
crescendo manner leading to the importance and
justification of your study
• Do not state or test hypotheses other than yours
• Do estimate magnitudes
• Should usually stay in a Word page, and never
occupy more than 2 Word pages
Introduction
1. Keep problems open and undecided
2. Use the present tense for what is currently true
3. Use the past tense for previous findings
4. Use past tense to state the question
5. Avoid using names of other investigators
(unless you really want to review your paper)
6. Repeat key terms from the title
Introduction
Ways to signal the question
1. To determine whether . . .
2. The purpose of this study was . . .
3. Therefore, we tested the hypothesis . . .
4. This report describes experiments designed
to determine whether . . .
5. Therefore, our first objective in these studies
was to determine whether . . .
6. In this study, we sought to extend our
observations and to specifically test . . .
Background: nature and scope of problem
“Restenosis after an initially successful
percutaneous coronary stent
implantation remains an important
unsolved problem. Retrospective studies
have found that several clinical,
angiographic, and procedural variables
are important predictors of restenosis.1-4”
The gap
“There is considerable variation among retrospective studies, however, and the results are often difficult to interpret.2-5 Prospective trials are clearly needed to confirm the results made in retrospective studies and to assess whether the risk of restenosis can be predicted accurately in specific patients.”
Previous findings
“Several studies have reported high
rates of restenosis among patients
with insulin-dependent diabetes,6-8
as well as among those with non-
insulin-dependent diabetes.2,6-9”
The question
“Therefore, we designed a prospective trial to test whether abnormal glucose tolerance and insulin resistance increases the likelihood of restenosis. Strategies to optimize glicemic control may indeed reduce the likelihood of restenosis.”
An example
Fajadet et al, Circulation 2006
Another example
Svilaas et al, NEJM 2008
Another example
Svilaas et al, NEJM 2008
Questions?
Take home messages
Remember the KUQE approach!
Take home messages
• Known
• Unknown
• Question
• Experimental approach
Remember the KUQE approach!
Take home messages
And now a brief break…
For further slides on these topics please feel free to visit the
metcardio.org website:
http://www.metcardio.org/slides.html